Charles River Laboratories International, Inc. (CRL) was a big mover last session with its shares rising just over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above past one month’s volatile price range of $52.24 to $55.91.
This provider of research models and associated services and outsourced preclinical services for drug development has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Charles River Laboratories currently holds a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Investors interested in the medical services industry may also consider stocks like ICON plc (ICLR), PAREXEL International Corporation (PRXL) and Omnicare Inc. (OCR). While ICON plc and PAREXEL sport a Zacks Rank #1 (Strong Buy), Omnicare bears the same Zacks Rank as Charles River Laboratories.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
CHARLES RIV LABS INTL INC (CRL): Free Stock Analysis Report
ICON PLC ORD (ICLR): Free Stock Analysis Report
PAREXEL INTL CP (PRXL): Free Stock Analysis Report
OMNICARE INC (OCR): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Personal Investing Ideas & Strategies
- Charles River Laboratories